Dundee
United Kingdom
32
2010-06-10
13
2015-11-03
These are the the leading inventors for applications assigned to CYCLACEL LIMITED:
CYCLACEL LIMITED based in Dundee, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders
#2 | 2010-05-20 ✅ Patent 8,536,188 granted on 2013-09-17Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
#3 | 2010-04-15 ✅ Patent 8,592,581 granted on 2013-11-26Trisubstituted purine derivatives
#4 | 2009-12-244-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy
#5 | 2009-08-274-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase Inhibitors
#6 | 2008-12-25Compounds
#7 | 2008-11-20 ✅ Patent 7,897,605 granted on 2011-03-01Pyrimidine compounds
#8 | 2008-10-09Methods and Means For Inhibition of CDK4 Activity
#9 | 2008-06-05Method for Identifying Inhibitors Using a Homology Model of Polo-Like Kinase 1
#10 | 2008-05-29Purine and Pyrimidine Cdk Inhitbitors and Their use for The Treatment of Autoimmune Diseases
#11 | 2007-11-22 ✅ Patent 7,772,207 granted on 2010-08-10Combination of a CDK inhibitor and CS-682 or a metabolite thereof
#12 | 2007-08-09Inhibitors of cyclin dependent kinases as anti-cancer agent
#13 | 2007-01-25 ✅ Patent 7,902,361 granted on 2011-03-08Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
#14 | 2007-01-252-Aminophenyl-4-phenylpyrimidines as kinase inhibitors
#15 | 2006-12-28P21 derived peptides and uses thereof
#16 | 2006-12-26 ✅ Patent 7,153,931 granted on 2006-12-26Transport vectors
#17 | 2006-11-23 ✅ Patent 7,576,091 granted on 2009-08-18Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases
#18 | 2006-10-26Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
#19 | 2006-09-07 ✅ Patent 7,427,627 granted on 2008-09-23N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
#20 | 2006-08-17 ✅ Patent 7,544,689 granted on 2009-06-09Purine derivatives
#21 | 2006-07-20 ✅ Patent 7,749,988 granted on 2010-07-06Triterpenoid derivatives
#22 | 2006-07-06Combination comprising a CDK inhibitor and a topoisomerase 1 inhibitor for the treatment of cancer and other proliferative diseases
#23 | 2005-12-15Combination comprising docetaxel and a CDK inhibitor
#24 | 2005-12-15Combination comprising a CDK inhibitor and cisplatin
#25 | 2005-12-01Pharmaceutical composition comprising a CDK inhibitor and gemcitabine
#26 | 2005-11-24Combination of a CDK inhibitor and mitoxantrone
#27 | 2005-11-17 ✅ Patent 7,582,642 granted on 2009-09-01Purine derivatives
#28 | 2005-10-06Combination comprising a CDK inhibitor and doxorubicin
#29 | 2005-09-29Bisarylsulfonamide compounds and their use in cancer therapy
#30 | 2005-07-28Combination of a cdk inhibitor and 5-fu for the tratment of cancer
#31 | 2005-07-21 ✅ Patent 7,312,356 granted on 2007-12-25Medicament
#32 | 2005-07-14Methods of treatment of chronic lymphocytic leukemia using roscovitine
219480 ⎘